T. Okuyama

474 citations
8 papers · 397 indexed · h-index 6
Topics
Peroxisome Proliferator-Activated Receptors (2 papers)Inflammatory mediators and NSAID effects (2 papers)Traditional Chinese Medicine Studies (2 papers)
Partner nations
Japan

In The Last Decade

T. Okuyama

8 papers receiving 389 citations

Peers

T. Okuyama
Comparison fields: 5 of 61
  • Molecular Biology 275
  • Cancer Research 143
  • Surgery 96
  • Pharmacology 96
  • Oncology 68
Replace Kazuya Isobe with:
Kazuya Isobe Japan
Gillian Moore Ireland
S Kinugasa Japan
T Kato Japan
Qin Fang China
Hiromi Hanaka Japan
Agnes Rasmuson Sweden
Yong Cheng China
Rongyang Dai China
Labile Togba Soumaoro Japan
T. Okuyama relative to Kazuya Isobe Japan Kazuya Isobe's profile →
Citations per field
00.5×3.1×
Kazuya Isobe · 1×
Citations per year

Countries citing papers authored by T. Okuyama

Since Specialization
Citations

This map shows the geographic impact of T. Okuyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Okuyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Okuyama more than expected).

Fields of papers citing papers by T. Okuyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Okuyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Okuyama. The network helps show where T. Okuyama may publish in the future.

Co-authorship network of co-authors of T. Okuyama

This figure shows the co-authorship network connecting the top 25 collaborators of T. Okuyama. A scholar is included among the top collaborators of T. Okuyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Okuyama. T. Okuyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 37
2 7
3 76
4 11
5 191
6 71
7
A study of the quantitative analysis on the mineral contents of the bone by x-rays.
1
8
[A study of the quantitative analysis on the mineral contents of the bone by x-rays].
3

About T. Okuyama

T. Okuyama is a scholar working on Complementary and alternative medicine, Small Animals and Cancer Research, having authored 8 papers that have together received 397 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Traditional Chinese Medicine Studies (2 papers). The work is most often cited by research in Cancer Research (143 citations), Pharmacology (96 citations) and Genetics (53 citations). T. Okuyama has collaborated with scholars based in Japan. Frequent co-authors include Hideaki Kazumori, M. A. Karim Rumi, Shunji Ishihara, Naofumi Nagasue, Ryo Fukuda, Hiroshi Sato, Kousaku Kawashima, H. Suetsugu, Nobuyuki Moriyama and Yuta Kinoshita. Their work appears in journals such as British Journal of Cancer, Alimentary Pharmacology & Therapeutics and Xenotransplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026